ZA986277B
(en )
1999-04-15
Tumor rejection antigens presented by HLA-B44 molecules and uses thereof
ZA961481B
(en )
1996-07-23
Isolated nonapeptides presented by hla molecules and uses thereof
IL122428A0
(en )
1998-06-15
Minizymes and minribozymes and uses thereof
EP0839125A4
(en )
2002-10-30
Novel cationic lipids and the use thereof
HUP9900330A3
(en )
2001-08-28
Pyrrolopyrimidines and processes for the preparation thereof
HU9602104D0
(en )
1996-09-30
Novel medicines and their use
IL118442A0
(en )
1996-09-12
Triazolymethyl-cyclopentanols their preparation and use
IL118441A0
(en )
1996-09-12
Triazolymethyl-oxiranes their preparation and use
AU2391195A
(en )
1995-11-16
Lymphocyte activation antigens and antibodies thereto
HUP0000318A3
(en )
2002-02-28
Tumor vaccine and process for the preparation thereof
ZA962280B
(en )
1996-08-28
RAGE tumor rejection antigens
EP0805161A4
(en )
2001-03-21
(1-3)-beta-d-glucan-binding protein, antibody that recognizes the protein, and use of the protein and antibody
EP0761718A3
(en )
1997-05-02
Process for the preparation of poly-o-hydroxyamides and poly-o-mercaptoamides
GB9520739D0
(en )
1995-12-13
HIV specific synthetic antigens and their use
GB9516293D0
(en )
1995-10-11
Novel peptides and their use as vaccines
AU2247095A
(en )
1995-10-30
Cellular immune response-specific antigens and uses therefor
AU5688596A
(en )
1996-10-30
Anti-cd14 antibodies for use in the induction of il-10 secre tion
ZA96240B
(en )
1997-07-14
Novel peptides their preparation and use
AU5429896A
(en )
1996-10-08
Rage tumor rejection antigens
AU5014896A
(en )
1996-10-16
Antibody to human betacellulin and use thereof
HUP9801330A3
(en )
2000-11-28
Novel pka-binding proteins and uses thereof
ZA96239B
(en )
1997-07-14
Novel peptides their preparation and use
ZA958037B
(en )
1996-06-06
Tumor rejection antigens presented by HLA-b44 molecules and uses thereof
IL122686A0
(en )
1998-08-16
Benzylhydroxylamines their preparation and use
IL118444A0
(en )
1996-09-12
Mercapto-triazolyl-silanes their preparation and use